Baroness Delyth Morgan, Chief Executive at Breast Cancer Now said: “As lockdown restrictions ease in England, and we look ahead to a ‘...

15 April 2021

Baroness Delyth Morgan, Chief Executive at Breast Cancer Now, said:   “Approval of Phesgo1 being used on the NHS in England...

4 April 2021

Responding to a new study into the treatment of early breast cancer in the UK, between March and May 2020, led by the University of Manchester and...

29 March 2021

A new study funded by the World Cancer Research Fund (WCRF) examined people’s exposure to modifiable risk factors using data from the Health...

25 March 2021

NHS England cancer waiting times data from January 2021 (published on Thursday 11 March 2020) shows: The two week wait target for people...

15 March 2021

Dr Simon Vincent, Director of Research, Support and Influencing at Breast Cancer Now said: “For people with breast cancer, having certain...

11 March 2021

The National Institute for Health and Care Excellence (NICE) has today (Friday 26 February 2021) announced its decision to approve ribociclib with...

26 February 2021

The National Institute for Health and Care Excellence (NICE) has today (Friday 12 February 2021) announced its decision to provisionally not...

12 February 2021

Dr Simon Vincent, Director of Research, Support and Influencing at Breast Cancer Now, said: “Breast cancer is the most common form of cancer...

5 February 2021